טוען...
The role of metabolic therapy in treating glioblastoma multiforme
Glioblastoma multiforme (GBM) is an aggressive and nearly uniformly fatal malignancy of the central nervous system. Despite extensive research and clinical trials over the past 50 years, very little progress has been made to significantly alter its lethal prognosis. The current standard of care (SOC...
שמור ב:
| הוצא לאור ב: | Surg Neurol Int |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405891/ https://ncbi.nlm.nih.gov/pubmed/25949849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.155259 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|